The pharmacotherapy of anxiety disorders has revolutionary changed in the last few years. This ICD-10 based review of the literature provides help for general practitioners and other specialists in the short and long term treatment of anxiety as well as in the discontinuation of pharmacologic treatment. The author describes the use of high potency benzodiazepines, selective serotonin reuptake inhibitors and 5 HT1A partial agonists and summarizes the disadvantages of some older drugs still in use for the treatment of anxiety disorders.
|Translated title of the contribution||Pharmacotherapy of anxiety disorders|
|Number of pages||5|
|Publication status||Published - nov. 5 1995|
ASJC Scopus subject areas